We hereby submit Intimation of Schedule of Analyst/Investor Meet/Conference.

YH/SE/59/2025-26 November 11, 2025

The Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1 G Block, Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051, India

Dept. of Listing Operations BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, India

Symbol: YATHARTH ISIN: INE0JO301016

Scrip Code: 543950 ISIN: INE0JO301016

Subject: Intimation of Schedule of Analysts/Investors meet /conference under Regulation 30

of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir/Madam,

In pursuance of Regulation 30(6) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby wish to inform you that the management of the Company will be participating in the following Analyst / Investor’s Meeting / Conference. The details are as below:

Date

November 14, 2025

Particulars of Investor Event/Meeting Anandrathi G200 Summit

Location Type of Event/

Organized By

Mumbai

meeting Investor Conference

Anandrathi Institutional Equities

The date of the aforesaid meeting/conference is subject to change due to exigencies on the part of Investors/Company. No Unpublished Price Sensitive Information will be shared at the above-mentioned meeting.

The aforesaid information will also be hosted on the website of the company at https://www.yatharthhospitals.com/investors

This is for your kind information and records.

Thanking You

Yours Faithfully, For Yatharth Hospital & Trauma Care Services Limited

Ritesh Mishra Company Secretary & Compliance Officer M. No. A51166